Inovio Pharmaceuticals, Inc. (AMEX: INO) reported Q4 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $2.1 million.

For earnings history and earnings-related data on Inovio Pharmaceuticals, Inc. (INO) click here.

Earnings